270 related articles for article (PubMed ID: 35971846)
1. Targeted NIR-responsive theranostic immuno-nanomedicine combined TLR7 agonist with immune checkpoint blockade for effective cancer photothermal immunotherapy.
Yasothamani V; Vivek R
J Mater Chem B; 2022 Aug; 10(33):6392-6403. PubMed ID: 35971846
[TBL] [Abstract][Full Text] [Related]
2. Photothermal-Activatable Fe
Ge R; Liu C; Zhang X; Wang W; Li B; Liu J; Liu Y; Sun H; Zhang D; Hou Y; Zhang H; Yang B
ACS Appl Mater Interfaces; 2018 Jun; 10(24):20342-20355. PubMed ID: 29878757
[TBL] [Abstract][Full Text] [Related]
3. The dynamic therapeutic effect of a targeted photothermal nanovaccine incorporating toll-like receptor 7 agonist enhanced cancer immunotherapy.
Karthikeyan L; Rithisa B; Vivek R
J Mater Chem B; 2023 Sep; 11(37):9005-9018. PubMed ID: 37712149
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Effect of Photothermally Targeted NIR-Responsive Nanomedicine-Induced Immunogenic Cell Death for Effective Triple Negative Breast Cancer Therapy.
Yasothamani V; Karthikeyan L; Shyamsivappan S; Haldorai Y; Seetha D; Vivek R
Biomacromolecules; 2021 Jun; 22(6):2472-2490. PubMed ID: 34014660
[TBL] [Abstract][Full Text] [Related]
5. Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effect.
Chen B; Huang R; Zeng W; Wang W; Min Y
Biomaterials; 2024 Mar; 305():122434. PubMed ID: 38141501
[TBL] [Abstract][Full Text] [Related]
6. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
[TBL] [Abstract][Full Text] [Related]
7. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
[TBL] [Abstract][Full Text] [Related]
8. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy.
Chen Q; Xu L; Liang C; Wang C; Peng R; Liu Z
Nat Commun; 2016 Oct; 7():13193. PubMed ID: 27767031
[TBL] [Abstract][Full Text] [Related]
9. Light-triggered multifunctional nanoplatform for efficient cancer photo-immunotherapy.
Yue J; Mei Q; Wang P; Miao P; Dong WF; Li L
J Nanobiotechnology; 2022 Apr; 20(1):181. PubMed ID: 35392911
[TBL] [Abstract][Full Text] [Related]
10. Black porous silicon as a photothermal agent and immunoadjuvant for efficient antitumor immunotherapy.
Xu W; Pang C; Song C; Qian J; Feola S; Cerullo V; Fan L; Yu H; Lehto VP
Acta Biomater; 2022 Oct; 152():473-483. PubMed ID: 36087872
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer.
Zhao P; Xu Y; Ji W; Zhou S; Li L; Qiu L; Qian Z; Wang X; Zhang H
J Nanobiotechnology; 2021 Jun; 19(1):181. PubMed ID: 34120612
[TBL] [Abstract][Full Text] [Related]
12. Precision USPIO-PEG-SLe
Li T; Guo L; Li J; Mu X; Liu L; Song S; Luo N; Zhang Q; Zheng B; Jin G
Int J Nanomedicine; 2024; 19():1249-1272. PubMed ID: 38348177
[TBL] [Abstract][Full Text] [Related]
13. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
Xu J; Xu L; Wang C; Yang R; Zhuang Q; Han X; Dong Z; Zhu W; Peng R; Liu Z
ACS Nano; 2017 May; 11(5):4463-4474. PubMed ID: 28362496
[TBL] [Abstract][Full Text] [Related]
14. Surface-Functionalized Modified Copper Sulfide Nanoparticles Enhance Checkpoint Blockade Tumor Immunotherapy by Photothermal Therapy and Antigen Capturing.
Wang R; He Z; Cai P; Zhao Y; Gao L; Yang W; Zhao Y; Gao X; Gao F
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13964-13972. PubMed ID: 30912920
[TBL] [Abstract][Full Text] [Related]
15. Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death.
Moon Y; Shim MK; Choi J; Yang S; Kim J; Yun WS; Cho H; Park JY; Kim Y; Seong JK; Kim K
Theranostics; 2022; 12(5):1999-2014. PubMed ID: 35265195
[No Abstract] [Full Text] [Related]
16. Immunoadjuvant-Modified
Niu MT; Chen QW; Chen Z; Liu X; Huang QX; Liang JL; Zhong Z; Cheng H; Zhang XZ
Nano Lett; 2024 Jan; 24(1):130-139. PubMed ID: 38150297
[TBL] [Abstract][Full Text] [Related]
17. Combined photothermal-immunotherapy
Huang X; Tian X; Zhang Q; Hu H; Gao J; Ma B; Wu K; Bai J; Du S; Lu Y; Han N
Biomater Sci; 2021 Sep; 9(18):6282-6294. PubMed ID: 34378577
[TBL] [Abstract][Full Text] [Related]
18. Targeting the tumor microenvironment with amphiphilic near-infrared cyanine nanoparticles for potentiated photothermal immunotherapy.
Noh I; Son Y; Jung W; Kim M; Kim D; Shin H; Kim YC; Jon S
Biomaterials; 2021 Aug; 275():120926. PubMed ID: 34147723
[TBL] [Abstract][Full Text] [Related]
19. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
[TBL] [Abstract][Full Text] [Related]
20. Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy.
Zhao P; Xu Y; Ji W; Li L; Qiu L; Zhou S; Qian Z; Zhang H
Int J Nanomedicine; 2022; 17():73-89. PubMed ID: 35027827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
